Reverse transcriptase selection can make or break your molecular biology experiments. From thermostability to fidelity, each feature impacts cDNA yield and accuracy. Understanding your RNA quality, ...
Is it the flu, COVID or something else? That old rapid antigen test sitting in your cupboard may tell you. But this is what ...
Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...
MedPage Today on MSN
FDA Approves New Standalone Combo Pill for HIV
Islatravir-doravirine matched alternate regimens in two phase III trials ...
The FDA has approved Idvynso (doravirine/islatravir) for virologically suppressed adults with HIV-1 as a replacement for current treatment regimens.
Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds ‑treatment ...
FDA approves doravirine/islatravir, a once-daily, 2-drug, single-tablet HIV regimen showing noninferior efficacy to standard ...
Posters detail large gene insertion and epigenetic editing capabilities, expanding ElevateBio’s gene editing toolbox ...
Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a ...
Health and Me on MSN
US FDA approves Merck’s once-daily combination pill for treating adults with HIV
According to the latest data from UNAIDS, 40.8 million people globally were living with HIV in 2024. Of these, 39.4 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results